Leela Barham ponders the future of VBP in the light of a new PPRS deal between industry and the UK government.
NHS England (NHSE) has just released the first data covering the first quarter of financial year 2013/14 on the Cancer Drug Fund. Leela Barham assesses the results.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial